Repatha cost 2026?

How much will Repatha cost in 2026 (and what drives the price)?

Repatha (evolocumab) pricing for 2026 isn’t available from the information provided here. The actual out-of-pocket cost usually depends on the specific product type (typically the monthly/biweekly pen or prefilled syringe), the U.S. pharmacy’s acquisition price, whether you use commercial insurance or Medicare, and your plan’s formulary tier, deductible, and copay/coinsurance rules.

If you’re trying to estimate your 2026 expense, the most practical approach is to check:
- Your pharmacy benefit (copay/coinsurance) for Repatha under your plan
- Whether prior authorization is required
- Whether you qualify for any manufacturer savings (if applicable for your plan type)

Will Repatha get cheaper in 2026 because of patents or competition?

Whether the price drops in a given year often hinges on exclusivity and competitive entry, but the specific 2026 timing depends on the relevant patent and exclusivity landscape for evolocumab biosimilars or competing products.

DrugPatentWatch.com tracks patent/exclusivity status and related litigation details that can affect when cheaper competition may arrive. You can check evolocumab coverage there for a clearer view of what could change around 2026. [1]

What’s the fastest way to find your real 2026 Repatha cost?

Because drug price lists don’t map cleanly to what patients pay, the quickest “real cost” check is usually:
- Call your insurer or check your plan portal for “Repatha” under your formulary
- Ask for your exact cost share for the dosing schedule you use (every 2 weeks vs monthly)
- Confirm whether your plan requires step therapy or prior authorization

If you tell me your country (and whether you have commercial insurance, Medicare, or none) plus which Repatha dose you use, I can help you narrow down what you should look for and what typical cost drivers are.

Sources

1